﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2023v5.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-09-26T14:20:07-05:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>582676261</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>Rogers &amp; Company PLLC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>8300 Boone Boulevard Suite 600</AddressLine1Txt>
        <CityNm>Vienna</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>22182</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>530214882</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>American Foundation for Pharmaceutical</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>Education</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>AMER</BusinessNameControlTxt>
      <PhoneNum>5714040471</PhoneNum>
      <USAddress>
        <AddressLine1Txt>11325 Random Hills Rd Ste 360A-105</AddressLine1Txt>
        <CityNm>Fairfax</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>220306051</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>Ellen L Woods</PersonNm>
      <PersonTitleTxt>President</PersonTitleTxt>
      <PhoneNum>5714040471</PhoneNum>
      <SignatureDt>2024-09-26</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>1</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>Lori A Collingsworth</PreparerPersonNm>
      <PTIN>P00639819</PTIN>
      <PhoneNum>7038930300</PhoneNum>
      <PreparationDt>2024-09-25</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-08-08 14:25:15Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="7">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>Ellen L Woods</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>11325 Random Hills Rd Ste 360A-105</AddressLine1Txt>
        <CityNm>Fairfax</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>220306051</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>1349892</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>https://afpepharm.org/</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1942</FormationYr>
      <LegalDomicileStateCd>NY</LegalDomicileStateCd>
      <ActivityOrMissionDesc>Advance &amp; support pharmaceutical sciences education at U.S. schools and colleges of pharmacy.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>17</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>16</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>2</TotalEmployeeCnt>
      <TotalVolunteersCnt>25</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>288119</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>306598</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>218298</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>266013</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>1673</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>7446</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>508090</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>580057</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>314750</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>281000</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>385857</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>400700</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>60238</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>91095</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>118362</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>791702</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>800062</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-283612</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-220005</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>9801168</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>10710645</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>118865</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>114136</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>9682303</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>10596509</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>To advance and support pharmaceutical sciences education at U.S. schools and colleges. See Schedule O for full mission.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>460404</ExpenseAmt>
      <GrantAmt>205000</GrantAmt>
      <Desc>Pre-Doctoral Fellowship: To encourage outstanding pre-doctoral students, who have completed at least three semesters of graduate study and have not more than three and a half years remaining, to continue their studies and earn the Ph.D. in the pharmaceutical sciences at a U.S. school or college of pharmacy. Applications are encouraged from students with the following majors: Clinical Pharmaceutical Science, Medicinal/Pharmaceutical Chemistry, Pharmaceutical Sciences, Pharmaceutics, Pharmacoeconomics &amp; Health Outcomes Research, Pharmacognosy, Pharmacokinetics/Metabolism, Pharmacology/Toxicology, Pharmacotherapy &amp; Experimental Therapeutics, Social &amp; Administrative, Pharmacogenomics/Informatics and Biomedical/Neural. See Schedule O for continuation.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>78606</ExpenseAmt>
        <GrantAmt>35000</GrantAmt>
        <Desc>AFPE Gateway to Research Awards: The purpose of the AFPE Gateway Research Scholarship is to provide pre-professional degree pharmacy students or baccalaureate degree students a scholarship supporting their participation in a faculty-mentored research project. The program teaches students to learn to identify relevant research problems; generate a research hypothesis; analyze data, how to interpret and use research results in practice; learn to effectively communicate the research and clinical data to medical professionals, patients, caregivers and peers; develop problem solving skills; sharpen critical thinking skills; understand regulatory and ethical principles that impact the research; and work as part of a team. See Schedule O for continuation.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>92080</ExpenseAmt>
        <GrantAmt>41000</GrantAmt>
        <Desc>Other Awards: AACP Social and Administrative Sciences (SAS) Section Summer Research Exchange Mentorship Program: The SAS Research Exchange Mentorship Program is intended to foster interest in research and SAS-related graduate education among student pharmacists. The program is open to P1-P3 students, who complete a research experience with a SAS faculty member outside their home institution, building their professional network and skills for residency, fellowship, and further graduate studies.See Schedule O for continuation.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>631090</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>1</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">1</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>0</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>2</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>17</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>16</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>0</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>AL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>AR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>AK</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CO</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>DC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>FL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>GA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>HI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KS</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>LA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>ME</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MS</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NM</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>ND</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OK</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>RI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>SC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WV</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>Ellen L Woods</PersonNm>
        <PhoneNum>5714040471</PhoneNum>
        <USAddress>
          <AddressLine1Txt>11325 Random Hills Rd Ste 360A-105</AddressLine1Txt>
          <CityNm>Fairfax</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>220306051</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>Ellen L Woods</PersonNm>
        <TitleTxt>President and Secretary</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>241395</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>47731</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Calvin Knowlton</PersonNm>
        <TitleTxt>Chair</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Lucinda Maine</PersonNm>
        <TitleTxt>Vice Chair</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>John Couric</PersonNm>
        <TitleTxt>Treasurer</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Karl Williams</PersonNm>
        <TitleTxt>General Counsel</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>John Bentley</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>J Lyle Bootman</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Craig Cox</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Rob DiCenzo</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Joe DiPiro</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Carol Gloff</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>David Gregory</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Anandi Law</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Russell Melchert</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Shawna Reagan</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Peter Swaan</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Lee Vermeulen</PersonNm>
        <TitleTxt>Member</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>241395</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>47731</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <GovernmentGrantsAmt>57214</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>249384</AllOtherContributionsAmt>
      <NoncashContributionsAmt>8631</NoncashContributionsAmt>
      <TotalContributionsAmt>306598</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>263133</TotalRevenueColumnAmt>
        <ExclusionAmt>263133</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>772715</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>769835</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>2880</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>2880</TotalRevenueColumnAmt>
        <ExclusionAmt>2880</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>Grant refunds</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>7446</TotalRevenueColumnAmt>
        <ExclusionAmt>7446</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>7446</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>580057</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>273459</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>20000</TotalAmt>
        <ProgramServicesAmt>20000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>261000</TotalAmt>
        <ProgramServicesAmt>261000</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>289126</TotalAmt>
        <ProgramServicesAmt>239973</ProgramServicesAmt>
        <ManagementAndGeneralAmt>19566</ManagementAndGeneralAmt>
        <FundraisingAmt>29587</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>74661</TotalAmt>
        <ProgramServicesAmt>61969</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5053</ManagementAndGeneralAmt>
        <FundraisingAmt>7639</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>12755</TotalAmt>
        <ProgramServicesAmt>10587</ProgramServicesAmt>
        <ManagementAndGeneralAmt>863</ManagementAndGeneralAmt>
        <FundraisingAmt>1305</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>6938</TotalAmt>
        <ProgramServicesAmt>5759</ProgramServicesAmt>
        <ManagementAndGeneralAmt>470</ManagementAndGeneralAmt>
        <FundraisingAmt>709</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>17220</TotalAmt>
        <ProgramServicesAmt>14293</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1165</ManagementAndGeneralAmt>
        <FundraisingAmt>1762</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>30638</TotalAmt>
        <ManagementAndGeneralAmt>30638</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>44347</TotalAmt>
        <ManagementAndGeneralAmt>44347</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <OfficeExpensesGrp>
        <TotalAmt>8552</TotalAmt>
        <ProgramServicesAmt>2896</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4981</ManagementAndGeneralAmt>
        <FundraisingAmt>675</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>14344</TotalAmt>
        <ProgramServicesAmt>12049</ProgramServicesAmt>
        <ManagementAndGeneralAmt>800</ManagementAndGeneralAmt>
        <FundraisingAmt>1495</FundraisingAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>900</TotalAmt>
        <ProgramServicesAmt>746</ProgramServicesAmt>
        <ManagementAndGeneralAmt>77</ManagementAndGeneralAmt>
        <FundraisingAmt>77</FundraisingAmt>
      </OccupancyGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>1170</TotalAmt>
        <ProgramServicesAmt>1028</ProgramServicesAmt>
        <FundraisingAmt>142</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>106</TotalAmt>
        <ManagementAndGeneralAmt>106</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>2003</TotalAmt>
        <ProgramServicesAmt>667</ProgramServicesAmt>
        <ManagementAndGeneralAmt>668</ManagementAndGeneralAmt>
        <FundraisingAmt>668</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>Charitable registration</Desc>
        <TotalAmt>16179</TotalAmt>
        <FundraisingAmt>16179</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Grant/award expenses</Desc>
        <TotalAmt>123</TotalAmt>
        <ProgramServicesAmt>123</ProgramServicesAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>800062</TotalAmt>
        <ProgramServicesAmt>631090</ProgramServicesAmt>
        <ManagementAndGeneralAmt>108734</ManagementAndGeneralAmt>
        <FundraisingAmt>60238</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>253755</BOYAmt>
        <EOYAmt>307649</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>51384</BOYAmt>
        <EOYAmt>53034</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>52750</BOYAmt>
        <EOYAmt>51500</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>300</BOYAmt>
        <EOYAmt>300</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>12765</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>11811</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>954</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>9442979</BOYAmt>
        <EOYAmt>10297208</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>9801168</BOYAmt>
        <EOYAmt>10710645</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>10115</BOYAmt>
        <EOYAmt>5386</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>108750</BOYAmt>
        <EOYAmt>108750</EOYAmt>
      </GrantsPayableGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>118865</BOYAmt>
        <EOYAmt>114136</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>8146304</BOYAmt>
        <EOYAmt>8856778</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>1535999</BOYAmt>
        <EOYAmt>1739731</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>9682303</BOYAmt>
        <EOYAmt>10596509</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>9801168</BOYAmt>
        <EOYAmt>10710645</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-220005</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>1134211</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>501003</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>299920</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>416810</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>288119</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>306598</CurrentTaxYearAmt>
        <TotalAmt>1812450</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>501003</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>299920</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>416810</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>288119</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>306598</CurrentTaxYearAmt>
        <TotalAmt>1812450</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>471048</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>1341402</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>275191</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>251603</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>238181</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>224589</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>263133</CurrentTaxYearAmt>
        <TotalAmt>1252697</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <TotalSupportAmt>3065147</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>20885</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.43760</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.46730</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>4905066</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>699920</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>250000</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>5354986</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6127191</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>-972125</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>250000</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>4905066</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>5572308</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>679883</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>125000</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>6127191</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>5077183</BeginningYearBalanceAmt>
        <ContributionsAmt>185863</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>441762</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>132500</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>5572308</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>3881003</BeginningYearBalanceAmt>
        <ContributionsAmt>700000</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>796180</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>300000</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>5077183</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.68470</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.31530</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.00000</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>12765</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>11811</DepreciationAmt>
        <BookValueAmt>954</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>954</TotalBookValueLandBuildingsAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>1669921</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>1134211</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>1134211</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>535710</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>44347</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>44347</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>580057</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>755715</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesNotReportedAmt>0</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>755715</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>44347</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>44347</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>800062</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part V, Line 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>The Organization's endowment includes the Board-designated quasi-endowment and donor-restricted funds to support education awards programs. The endowment funds are to be used for the purpose of funding fellowship scholarships dedicated to the educational pursuit of the pharmaceutical sciences by the awardee students and faculty.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part X, Line 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>Management has evaluated the Organization's tax positions and concluded that the Organization's financial statements do not include any uncertain tax positions.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>American Association of Colleges of Pharmacy (AACP)</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1400 Crystal Dr 300</AddressLine1Txt>
          <CityNm>Arlington</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22202</ZIPCd>
        </USAddress>
        <RecipientEIN>362376972</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>20000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>Scholarship of Teaching and Learning (SOTL) Grant</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>1</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>AFPE Pre-Doctoral Fellowship Awards</GrantTypeTxt>
        <RecipientCnt>15</RecipientCnt>
        <CashGrantAmt>147500</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Gateway to Research Awards</GrantTypeTxt>
        <RecipientCnt>7</RecipientCnt>
        <CashGrantAmt>35000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>AACP Social and Administrative Sciences Summer Research Exchange Awards</GrantTypeTxt>
        <RecipientCnt>5</RecipientCnt>
        <CashGrantAmt>12500</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>AFPE Regional Award</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>10000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>ASHP-AFPE Pre-Doctoral Fellowship</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>10000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Dr. Paul Myrdal Memorial Fellowship</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>10000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Herb and Nina Demuth Memorial Award</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>10000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Phi Lambda- AFPE First Year Graduate School Fellowship</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>10000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Rho Chi - AFPE School Fellowship</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>7500</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Implementation Science Scholar</GrantTypeTxt>
        <RecipientCnt>2</RecipientCnt>
        <CashGrantAmt>5000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>ClinicalMind for Black Pharmacy Students</GrantTypeTxt>
        <RecipientCnt>2</RecipientCnt>
        <CashGrantAmt>2500</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>William M. Heller Faculty Mentor of the Year</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>AFPE has an application process for all scholarships and fellowships in Pharmaceutical Science. Awards are made payable directly to the universities of study.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Ellen L Woods</PersonNm>
        <TitleTxt>President and Secretary</TitleTxt>
        <BaseCompensationFilingOrgAmt>241395</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>26554</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>21177</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>289126</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 1, Description of Organization Mission:</FormAndLineReferenceDesc>
        <ExplanationTxt>The mission of the American Foundation for Pharmaceutical Education (AFPE) is to advance and support pharmaceutical sciences education at U.S. schools and colleges of pharmacy by: awarding fellowships and grants, recognizing and supporting talented students and faculty, encouraging exceptional students to pursue advanced degrees in pharmaceutical sciences, education outstanding industry ready pharmaceutical scientists, supporting pharmaceutical science faculty, and supporting state-of -the-sciences pharmaceutical education. Awarding Fellowships and Grants AFPE offers funding to first-year graduate students, Pharm.D.students, and pre-doctoral candidates, and faculty members. Recognizing and Supporting Talented Students and Faculty AFPE awards provide recognition and support to a diverse group of talented students and faculty as they pursue advanced pharmaceutical sciences education. These students and faculty develop state-of-the-science knowledge, skills, and techniques of great value to industry and academia as they prepare to participate effectively in achieving the business goals of pharmaceutical research and manufacturing and the academic goals of the pharmaceutical sciences education enterprise. Encouraging Exceptional Students to Pursue Advanced Degrees in Pharmaceutical Sciences AFPE First Year Graduate School Fellowships encourage the best U.S. students to pursue careers in the pharmaceutical sciences by supporting exceptional first- year of graduate school students as they begin a Ph.D. degree course of study in the pharmaceutical sciences in preparation for careers in industry and academia. Education Outstanding Industry Ready Pharmaceutical Scientists AFPE Pre-Doctoral Fellowships in the Pharmaceutical Sciences support the most exceptional Ph.D. students during the advanced, research phase of their pharmaceutical sciences course of study and enable them to focus intensively on industry-oriented subjects such as: drug development, drug delivery, clinical trial design and management, pharmacoeconomics, and manufacturing quality control. In the course of their graduate studies, AFPE Fellows receive drug-focused training, in-depth introductions to industry processes, and experience in the use of teamwork and cross-functional collaboration to achieve industry research, development, evaluation and manufacturing goals. Supporting Pharmaceutical Science Faculty AFPE is proud to support the American Association of Colleges of Pharmacy (AACP) in their strategic initiative, the Scholarship of Teaching and Learning Grants (SOTL), for enhancing and improving educational outcomes. SOTL provides research funding for faculty members who are engaging in educational research. Supporting State-of -the-Sciences Pharmaceutical Education AFPE supports graduate education, training and research in the pharmaceutical sciences in such disciplines as clinical pharmaceutical science, medicinal/pharmaceutical chemistry, pharmacology/toxicology, pharmaceutics, pharmacoeconomics, pharmacognosy, pharmacokinetics/metabolism, pharmacotherapy &amp; experimental therapeutics, and social &amp; administrative pharmacy. The interest of AFPE corporate and individual contributors in supporting new or evolving scientific fields helps pharmacy educators create state-of-the-art curricula to keep pace with today's rapid advances in drug discovery and development.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4a, Pre-Doctoral Fellowships: (continued)</FormAndLineReferenceDesc>
        <ExplanationTxt>The primary goal of the AFPE Pre-Doctoral Research Fellowship program is to positively impact patient and public health by supporting high performing students who possess the skill and aptitude to become outstanding scientists and leaders in the pharmaceutical industry, academia, and the government/nonprofit sectors. AFPE offers the following fellowships: AFPE Pre-Doctoral Research Fellowship in Pharmaceutical Sciences: The primary goal of the AFPE Pre-Doctoral Fellowship program is to support students who have leadership potential in the pharmaceutical industry, academia, and government. The pre-doctoral fellowships offered by AFPE frequently inspire the direction of our students' careers. Progress in research will require an infusion of new well-trained researchers entering the field. AFPE Regional Award: This award funds students eligible for an AFPE Pre-Doctoral Fellowship who live in Michigan, North Dakota, South Dakota, Minnesota, or Wisconsin, and have lived in one of those states for the past fifteen consecutive years. This award is funded by an endowment. ASHP-AFPE Pre-Doctoral Fellowship: This Fellowship supports research projects which focus on improving health outcomes in hospitals, health systems, and ambulatory care clinics. Pre-Doctoral Fellowship in Pharmaceutical Sciences for Underrepresented Minorities: Awarded to minority student(s) in a graduate PhD program in pharmaceutical science who have potential to contribute to the field and ultimately impact patient and public health. Dr. Paul B. Myrdal Memorial Pre-Doctoral Fellowship in Pharmaceutics: This fellowship, in memory of Dr. Paul B. Myrdal, is awarded to pre-doctoral and Pharm.D. students who are conducting research in the field of pharmaceutics. Herb and Nina Demuth Memorial Award: The Herb and Nina Demuth Memorial Award is given to pre-doctoral students whose research focuses on parenteral drugs. Kappa Epsilon - AFPE Graduate School Fellowship: Awarded to members of the Kappa Epsilon Fraternity to encourage outstanding members to pursue or continue an advanced degree in a college of pharmacy graduate program in the pharmaceutical sciences. Phi Lambda Sigma-AFPE Fellowship: Awarded to Phi Lambda Sigma members to encourage the pursuit of a PhD in the pharmaceutical sciences in a college of pharmacy graduate program. Rho Chi - AFPE School Fellowship: Awarded to members of the Rho Chi Honor Society who have demonstrated high potential for success in a graduate program (PharmD and/or PhD) based on academic achievement, research achievement, and personal achievement. Pre-Doctoral Award in Health Outcome Disparities: The Pre-Doctoral Award in Health Outcomes Disparities is fellowship for a pre-doctoral student whose research focuses on either a disease area which disproportionately impacts underserved populations, or whose research focuses on reducing healthcare disparities and improving health outcomes for underserved populations in the United States. Examples of this research could include sickle-cell anemia, asthma, HIV/AIDS, maternal and infant mortality, access to medication, etc.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4b, Gateway to Research Awards: (continued)</FormAndLineReferenceDesc>
        <ExplanationTxt>This award helps students to learn to identify relevant research problems, generate a research hypothesis, analyze data, learn how to interpret and use research results in practice, learn to effectively communicate research and clinical data to a broad audience, develop problem-solvingskills, and sharpen critical thinking skills. Overall the exposure to and understanding of research enables them to improve their clinical skills to facilitate better communication with patients and medical team members, thus equipping them for the changing healthcare workforce.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4c, Other Awards: (continued)</FormAndLineReferenceDesc>
        <ExplanationTxt>William M. Heller Mentor of the Year: The William M. Heller Mentor of the Year is a highly visible award. Mentors are an integral part of AFPE's mission. The Mentor of the Year is given to the AFPE mentor who exemplifies the characteristics of valuing ongoing learning, a willingness to share expertise, exhibiting enthusiasm in their field, providing guidance with respect, and is nominated by their mentees and colleagues. Scholarship of Teaching and Learning Grant: The Scholarship of Teaching and Learning Grants (SOTL) sponsored by the American Association of Colleges of Pharmacy (AACP) and AFPE provide research funding for active members of AACP who are engaging in educational research. ClinicalMind Scholarship for Black Pharmacy Students: The primary goal of the ClinicalMind Scholarship for Black Pharmacy Students is to fund black students pursuing a PharmD or Ph.D., in one of the following research areas: rare disease, gene therapy, small molecule therapeutics or underserved populations.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section A, line 1a</FormAndLineReferenceDesc>
        <ExplanationTxt>The Executive Committee is made up of the Chairman of the Board, the Vice-Chairman of the Board, the Treasurer, the Board of Grants Chair, General Counsel, and two representatives from pharmacy education. In addition, the President and Secretary shall be ex-officio members without vote, unless a member of the Board. During the intervals of time between meetings of the Board of Directors, the Executive Committee shall exercise all the powers of the Board and transact all the business of the Corporation, except the power to amend the Articles of Incorporation and the Bylaws.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, line 11b</FormAndLineReferenceDesc>
        <ExplanationTxt>The draft Form 990 is sent to the Finance Committee and subsequently sent to the Executive Committee for approval.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, line 12c</FormAndLineReferenceDesc>
        <ExplanationTxt>The Conflict of Interest Policy is provided in briefing books before each committee or board meeting and participants are asked to disclose any conflicts of interest with any agenda item.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, line 15a</FormAndLineReferenceDesc>
        <ExplanationTxt>Compensation Committee reviews compensation and the Board of Directors approves it.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section C, line 19</FormAndLineReferenceDesc>
        <ExplanationTxt>Governing documents, policies, and financial statements are available online and upon request.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part XII, Line 2c:</FormAndLineReferenceDesc>
        <ExplanationTxt>The Finance Committee assumes responsibility for oversight of the audit of its financial statements and selection of an independent accountant. The process is consistent with previous years.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>